Stacey D. Seltzer
Stacey Seltzer is a partner at Aisling Capital. Previously, Ms. Seltzer was at Schering-Plough, where she held roles in business development, marketing and sales, most recently serving as the U.S. Schering-Plough Brand Lead for Zetia. Prior to Schering-Plough, Ms. Seltzer was the Director of Business Development for Akceli, a biotechnology company developing cell-based microarrays. Ms. Seltzer began her career as a management consultant for McKinsey & Company. Ms. Seltzer serves as a director of Miramar Labs. Previously, she served as a Board observer for Agile Therapeutics, Durata Therapeutics and ZELTIQ Aesthetics.
She also acted as the Aisling representative for its investment in Precision Dermatology and was closely involved in Aisling’s investments in Cytos, Dermira and PowerVision. Ms. Seltzer received her MBA from The Wharton School at the University of Pennsylvania, where she was a Palmer Scholar. She received her MS and BS from Yale University, awarded cum laude in Molecular Biophysics and Biochemistry.